Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precisely Inhibiting Excessive Intestinal Epithelial Cell Apoptosis to Efficiently Treat Inflammatory Bowel Disease with Oral Pifithrin‐α Embedded Nanomedicine (OPEN)
Mingyuan Wang, Qiong Huang, Min Liu, et al.
Advanced Materials (2023) Vol. 35, Iss. 49
Closed Access | Times Cited: 22

Showing 22 citing articles:

Revitalizing Ancient Mitochondria with Nano‐Strategies: Mitochondria‐Remedying Nanodrugs Concentrate on Disease Control
Xingyu Long, Min Liu, Yayun Nan, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 18
Enzyme-like biomimetic oral-agent enabling modulating gut microbiota and restoring redox homeostasis to treat inflammatory bowel disease
Zhangpeng Shi, Xiaohong Li, Jufeng Chen, et al.
Bioactive Materials (2024) Vol. 35, pp. 167-180
Open Access | Times Cited: 13
Photothermal Microneedle Hydrogel Patch for Refractory Soft Tissue Injuries through Thermosensitized Anti‐Inflammaging Modulation
Wanbo Zhu, Quan Liu, Ziheng Zhang, et al.
Small Structures (2024) Vol. 5, Iss. 5
Open Access | Times Cited: 8
Engineered probiotics with sustained release of interleukin-2 for the treatment of inflammatory bowel disease after oral delivery
Maoyi Li, Nanhui Liu, Jiafei Zhu, et al.
Biomaterials (2024) Vol. 309, pp. 122584-122584
Closed Access | Times Cited: 6
Pathophysiology of IBD as a Key Strategy for Polymeric Nanoparticle Development
Elena Gardey, Johannes C. Brendel, Andreas Stallmach
Advanced Therapeutics (2025)
Open Access
An orally biological chemotaxis-guided hypoxia-responsive biomimetic microcapsules for visualizing multi-faceted synergistic therapy of inflammatory bowel disease
Yifei Wang, Yaning Xia, Mengyang Zhou, et al.
Chemical Engineering Journal (2025), pp. 160203-160203
Closed Access
The Alleviating Effect of Taxifolin on Deoxynivalenol-Induced Damage in Porcine Intestinal Epithelial Cells
Min Zhu, Yong-xia Fang, Yujie Cheng, et al.
Veterinary Sciences (2024) Vol. 11, Iss. 4, pp. 156-156
Open Access | Times Cited: 3
Highly Crystalline Copper Aluminum-Layered Double Hydroxides with Intrinsic Fenton-Like Catalytic Activity for Robust Oral Health Management
Danfeng Luo, Xiaocan Liu, Shuang Dai, et al.
Inorganic Chemistry (2024) Vol. 63, Iss. 23, pp. 10691-10704
Closed Access | Times Cited: 3
Reprogramming the myocardial infarction microenvironment with melanin-based composite nanomedicines in mice
Yamei Liu, Shuya Wang, Jiaxiong Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Artemisinins: Promising drug candidates for the treatment of autoimmune diseases
Xu Gao, Xian Lin, Qingwen Wang, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 2, pp. 867-891
Closed Access | Times Cited: 8
Mesenteric adipose-derived exosomal TINAGL1 enhances intestinal fibrosis in Crohn's Disease via SMAD4
Yidong Chen, Junrong Li, Xiao‐Peng Zhang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 2
Nitric Oxide‐Based Nanomedicines for Conquering TME Fortress: Say “NO” to Insufficient Tumor Treatment
Yuting Xiang, Qiaohui Chen, Yayun Nan, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 13
Closed Access | Times Cited: 6
Customized Proteinaceous Nanoformulation for In Vivo Chemical Reprogramming
Huating Chen, Jiangbing Xiang, Yawei Liu, et al.
Advanced Materials (2024) Vol. 36, Iss. 28
Closed Access | Times Cited: 1
Cell death pathways in inflammatory bowel disease
Kai Guo, Jimin Yin, Haodong Cui
World Journal of Surgical Infection (2024) Vol. 3, Iss. 1, pp. 24-31
Closed Access
Therapeutic implication of targeting mitochondrial drugs designed for efferocytosis dysfunction
Wan-Ting Liu, Chao-Quan Li, Ao-Ni Fu, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 10, pp. 1169-1185
Closed Access
Blueberry extract attenuates DSS-induced inflammatory bowel disease in mice through inhibiting ER stress-mediated colonic apoptosis in mice
Jun Wang, Xin-Yu Wang, Zhong-Yu Yuan, et al.
Food & Function (2024) Vol. 15, Iss. 18, pp. 9541-9551
Closed Access
Bioinspired micro-nano hierarchical delivery system for sequential targeted therapy of inflammatory bowel disease
Peipei Xi, Xiangyu Wei, Yongxin Xu, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155215-155215
Closed Access
Novel reduced heteropolyacid nanoparticles for effective treatment of drug-induced liver injury by manipulating reactive oxygen and nitrogen species and inflammatory signals
Yongqi Yang, Qiaohui Chen, Zerun Liu, et al.
Journal of Colloid and Interface Science (2024) Vol. 678, pp. 174-187
Closed Access
Peroxynitrite-Free Nitric Oxide-Embedded Nanoparticles Maintain Nitric Oxide Homeostasis for Effective Revascularization of Myocardial Infarcts
Jiaxiong Zhang, Shuya Wang, Quan Sun, et al.
ACS Nano (2024) Vol. 18, Iss. 47, pp. 32650-32671
Closed Access
Banana Starch Nanoparticles Disrupt the Integrity of the Intestinal Barrier by Opening Tight Junctions in Mice
Bing Jiang, Chenglu Peng, Xiaoyang Li, et al.
Small (2024)
Closed Access
Hierarchical Targeting Nanodrug with Holistic DNA Protection for Effective Treatment of Acute Kidney Injury
Qiaohui Chen, Yongqi Yang, Xiaohong Ying, et al.
Advanced Science (2024)
Open Access
Oral Lactoferrin‐Responsive Formulation Anchoring around Inflammatory Bowel Region for IBD Therapy
Jinfan Yang, Ning Shang, Zhengqing Li, et al.
Advanced Healthcare Materials (2024)
Closed Access
Page 1

Scroll to top